CACHET B/C
CACHET B/C
A trial comparing the safety and efficacy of bivalirudin/Angiomax plus abciximab with heparin plus abciximab in patients undergoing PCI.
Primary endpoints
In-hospital MACE.
Conclusion
Bivalirudin ± provisional abciximab had fewer major adverse outcomes than heparin/abciximab.Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
Copyright © 2003-2025 Farlex, Inc
Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.